“Doctor, agar mera weight kam ho jaye, toh kya fatty liver bhi theek ho sakta hai?”
According to Dr. Shivanshu Misra, this is one of the most important questions a person with obesity and fatty liver can ask.
The answer, in many cases, is yes.
Fatty liver is closely linked with obesity, insulin resistance and diabetes. When a person loses excess weight and improves their metabolic health, the amount of fat stored in the liver can come down. In some patients, even the inflammation associated with MASH or NASH can improve.
This is why Dr. Shivanshu Misra, a bariatric and metabolic surgeon, believes that weight management should be an important part of the conversation whenever obesity and fatty liver are found together.
Why does losing weight affect the liver?
The liver does not work separately from the rest of the body.
When a person has excess body fat, particularly abdominal fat, the body can become more resistant to insulin. Blood sugar may rise, diabetes can develop and fat metabolism can become disturbed.
Some of that excess fat can accumulate in the liver.
As the metabolic problem continues, some patients can develop inflammation and liver injury. This condition was traditionally called NASH — non-alcoholic steatohepatitis and is now increasingly called MASH — metabolic dysfunction-associated steatohepatitis.
Dr. Shivanshu Misra explains that this is why treating the underlying obesity and metabolic problem can be important for the liver as well.
Even weight loss can make a difference
Weight loss does not have to mean reaching an “ideal” weight overnight.
The body can start benefiting from meaningful weight reduction much earlier.
A recent systematic review and meta-analysis of randomised clinical trials found that greater total body weight loss was associated with higher rates of MASH resolution and improvement in liver fibrosis.
This is an important point for patients who feel that losing weight will only change their appearance.
For Dr. Shivanshu Misra, the benefits can go much deeper.
Losing excess weight can improve insulin resistance, blood sugar, blood pressure and other metabolic problems. At the same time, liver fat can decrease.
What happens to the fatty liver?
Imagine the liver as an organ that has gradually accumulated excess fat because the body’s metabolism is struggling.
When the underlying problem improves, the liver can also improve.
Research on bariatric interventions has found substantial reductions in liver fat after treatment. A 2024 systematic review and meta-analysis involving 30 studies and 3,134 patients reported a 72% reduction in intrahepatic fat measured by MRI-PDFF at six months after bariatric intervention. The study also found improvements in histological features associated with MASH.
This does not mean every patient will experience exactly the same result.
The response depends on the person’s obesity, diabetes, liver condition, fibrosis stage, lifestyle and several other factors.
But the overall message is encouraging.
Where does bariatric surgery come in?
This is where Dr. Shivanshu Misra’s work as a bariatric and metabolic surgeon becomes relevant.
Not every person with fatty liver needs bariatric surgery.
For someone with mild fatty liver and manageable weight, lifestyle changes, exercise, diet and appropriate medical treatment may be enough.
But for a person living with severe obesity, particularly when obesity is accompanied by type 2 diabetes and other metabolic problems, maintaining significant weight loss through lifestyle changes alone can be difficult.
For appropriately selected patients, bariatric surgery or metabolic surgery can produce substantial and sustained weight loss.
And that weight loss can have effects beyond the weighing scale.
Bariatric surgery is not just about weight
This is something Dr. Shivanshu Misra wants patients to understand.
Bariatric surgery is often described as “weight loss surgery.” But in patients with obesity and metabolic disease, its effects can extend to diabetes, insulin resistance and fatty liver disease.
A systematic review and meta-analysis of 30 studies found that bariatric interventions significantly reduced liver fat and improved several histological features of MASH.
Earlier biopsy-based evidence has also shown improvement in steatosis, inflammation and fibrosis following bariatric surgery.
For Dr. Shivanshu Misra, this is one reason metabolic surgery needs to be viewed in the context of the patient’s overall health rather than just the number of kilograms lost.
Can NASH actually reverse?
In some patients, yes.
But it is important to use the word “reverse” carefully.
Dr. Shivanshu Misra explains that improvement depends on how advanced the liver disease is.
If a patient has fatty liver without significant scarring, there can be considerable scope for improvement when the underlying metabolic problem is treated.
If inflammation has developed, weight loss may help resolve MASH/NASH in many patients.
Fibrosis is different. Scar tissue takes longer to change, and advanced fibrosis or cirrhosis requires specialist assessment.
A 2024 meta-analysis found that bariatric intervention was associated with improvements in several components of metabolic fatty liver disease, while more recent research continues to show a relationship between the amount of weight lost and improvement in liver histology.
So, the earlier the problem is identified, the better the opportunity to intervene.
What if the patient already has cirrhosis?
This is where people should not make their own treatment decisions.
Dr. Shivanshu Misra emphasises that a person with advanced liver disease needs proper evaluation before considering any surgical procedure.
Bariatric surgery has been studied mainly in people with obesity who are otherwise appropriate candidates. Its safety and role become much more complicated when advanced or decompensated cirrhosis is present. Older AASLD guidance specifically cautioned that the safety and efficacy of bariatric surgery in NASH cirrhosis were not well established.
Therefore, someone with suspected advanced fibrosis or cirrhosis needs assessment by an appropriate liver specialist and surgical team before any decision about metabolic surgery.
The goal is not just to lose weight
For Dr. Shivanshu Misra, the real goal is to improve the patient’s health.
A patient may come to a bariatric surgeon because of obesity.
But during evaluation, doctors may also find diabetes, high blood pressure, sleep problems or fatty liver.
That changes the conversation.
The question becomes:
“How can we improve the patient’s overall metabolic health?”
Weight loss becomes one part of that larger goal.
Dr. Shivanshu Misra on the liver and weight loss
The relationship between obesity and fatty liver is now difficult to ignore.
When excess weight contributes to insulin resistance and metabolic dysfunction, the liver can become one of the organs affected.
The positive side is that metabolic health can improve with appropriate intervention.
For some patients, lifestyle changes may be enough. For others with severe obesity, bariatric or metabolic surgery may be an appropriate option after proper evaluation.
As Dr. Shivanshu Misra, a bariatric and metabolic surgeon, explains, treating obesity can sometimes mean treating much more than obesity itself.
Reducing excess weight can reduce liver fat, improve metabolic health and, in appropriately selected patients, help reverse important changes associated with MASH/NASH.
The important thing is not to wait until fatty liver has progressed to advanced liver damage before taking action.
For more info visit : https://drshivanshumisra.com/